Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPAPY - Aspirin in acute pneumonia in the elderly
2024-510811-32-00Phase 3Authorised
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Acute pneumonia comparing Aspirin arm with Placebo arm (2 arms). Primary endpoint: All-cause mortality at day 90. Planned start Dec 2024; status: authorised.
02
Drugs
aspirin
03
Conditions
Acute pneumonia
Beyond the preview
Go deeper on 2024-510811-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510811-32-00.